Pre-Conference Workshops

Workshop A

Tuesday July 23, 8:00am – 11:00am

Understanding the Role of Genetics in Neuropsychiatric Disorders

Recent technological advances have provided us with the ability to understand the genetic influences on neurodevelopmental variation, as well as the ability to study differences within and between neuropsychiatric disorders. The genetic risk factors for severe neuropsychiatric disorders will be introduced in this workshop.

By attending this workshop, you will:

  • Be introduced to types of genetic variation
  • Learn about our current understanding of the role of genetics in different neuropsychiatric disorders
  • Discuss how this may affect our ability to treat these disorders in the future

Workshop Leader:

NPD Speakers

Elise Robinson
Assistant Professor
Harvard University

Workshop B

Tuesday July 23, 11:30am – 2:30pm

Reviewing the Potential for Precision Medicine in Neurological Diseases

With the advances in next-generation sequencing, the possibilities for genetic stratification of neuropsychiatric disease have great potential with both individual treatment optimization and clinical trial design.

Attend this workshop to:

  • Learn about the technology advances changing the precision medicine landscape
  • Understand which neuropsychiatric diseases would be most compatible for precision medicine treatment
  • Discuss and debate the pros and cons of the precision medicine approach
  • Review the available data for case studies of precision medicine

Workshop Leader:

NPD Speakers (1)

Christopher Missling
Chief Executive Officer
Anavex Life Sciences

Workshop C

Tuesday July 23, 3:00pm – 6:00pm

Mitigating Risk in CNS Clinical Trials

The frustrations and challenges in the neuropsychiatry space over the years have been evident. With large studies failing in phase II/III, drug development costs and timelines have skyrocketed, prompting many Industry leaders in the field to scrap their Psychiatry or CNS divisions. Innovators in Academia and Industry have stepped up efforts to mitigate risk and, hence, design and conduct to more effective and productive trials.

Attendees will discuss in detail:

  • Using clinically validated paradigms that don’t rely on pre-clinical models to mitigate risk in clinical trials
  • Review of successful study design elements
  • Review common pitfalls to avoid when designing and executing trials

Workshop Leader:

NPD Speakers (2)

George I Papakostas
Scientific Director
Massachusetts
General Hospital Clinical Trials Network and Institute